期刊文献+

嘧啶与吡啶衍生物硝化方法的改进 被引量:1

Superior Methodology for the Nitration of Pyrimidine and Pyridine Derivatives
下载PDF
导出
摘要 目的:改进6-氯-3-甲基脲嘧啶和2-羟基吡啶的硝化方法,分别制备6-氯-3-甲基-5-硝基脲嘧啶和2-羟基-3-硝基吡啶。方法:采用KNO3代替浓硝酸与浓硫酸组成的复合硝化剂分别对两原料进行硝化,同时考察原料与KNO3的摩尔比、加料温度以及反应时间和温度对硝化收率的影响,以确定最佳工艺条件。结果:适宜于6-氯-3-甲基脲嘧啶硝化和制备相应目标产物的反应条件是:原料与硝酸钾的摩尔比为1∶1.25~1∶1.3,加料温度为5℃,反应时间为2h,反应温度为25℃。而适宜于2-羟基吡啶硝化和制备相应目标产物的反应条件基本上与之相同,只是反应温度为45℃~50℃。两个目标产物的收率分别达53%和54%。结论:本方法操作简便,其反应温和、安全、易控,且收率较高。 Objective: To improve the process of the nitration of 6-chloro-3-methyluraeil and 2-hydroxypyridine as starting materials for the synthesis of 6-chloro-3-methyl-5-nitrouracil and 2-hydroxy- 3-nitropyridine. Methods: KNO3-H2SO4 was used as a mixed nitrating agent instead of HNO3-H2SO4 to nitrate the two starting materials respectively. The influences of starting material/KNO3 molar ratio,feeding temperature and nitration time and temperature on the nitration were investigated in order to find out a superior nitrating condition. Results: The conditions suitable for the nitration of 6-chloro-3-methylu- racil into corresponding target product were found as follows: a starting material/KNO3 molar ratio of 1 : 1.25-- 1 : 1.3, a feeding temperature of 5 ℃, a nitrating time of 2 h and a nitrating temperature of 25 ℃. The conditions suitable for the nitration of 2-hydroxypyridine into another target product were found substantially ditto except for a nitrating temperature of 45 ℃--50 ℃. The yields of the two target products were 53% and 54% respectively. Conclusion: The improved process is easy to operate in which the nitrating reaction is mild, safe and controllable with the higher yield.
出处 《药学进展》 CAS 2009年第3期131-133,共3页 Progress in Pharmaceutical Sciences
基金 国家自然科学基金资助项目(30572240) 国家基础科学人才培养基金资助项目(NFFTBS J0630858)
关键词 6-氯-3-甲基脲嘧啶 2-羟基吡啶 复合硝化剂 硝化反应 硝化收率 6-chloro-3-methyluracil 2-hydroxypyridine mixed nitrating agent nitration reaction nitrating yield
  • 相关文献

参考文献7

  • 1邓艳君,石静波,姜力勋,高静,姚其正.嘧啶并呋咱核苷衍生物的制备及其活性初探[J].化学学报,2006,64(18):1911-1915. 被引量:10
  • 2姚蒙正.硝化反应研究的近期进展[J].染料工业,1999,36(2):15-18. 被引量:12
  • 3吕春绪,蔡春.金属硝酸盐──醋酐硝化剂的研究[J].兵工学报,1994,15(2):42-45. 被引量:4
  • 4Smith K, Musson A, DeBoos G A. Superior methodology for the nitration of simple aromatic compounds [ J ]. J Chem Soc Chem Commun, 1996,4:469-470.
  • 5Daves G D, Robins R K, Cheng C C. Antibiotics Ⅰ:synthesis of 1,6-simethyl-5,7-dioxo-1,5,6,7-tetrahydropyrimido [ 5,4-e ] as-triazine (toxoflavin) and related com pounds[J].J Am Chem Soc,1962,84(9 ) :1724-1729.
  • 6Liao T K, Cheng C C. 1,3-Dimethyl-5-nitro-4-chlorouracil [ J ]. J Heterocycl Chem, 1964,1:212.
  • 7Hwang D R, Proctor G R, Driscoll J S. Pyridones as potential antitumor agents Ⅱ:4-pyridones and bioisosteres of 3- acetoxy-2-pyridone [ J ]. J Pharm Sci, 1980, 69 ( 9 ) : 1074-1076.

二级参考文献17

  • 1周发岐,炸药合成化学,1984年
  • 2奥尔布赖特 L F,工业与实验室硝化,1984年
  • 3Sako,M.; Oda,S.; Ohara,S.; Hirota,K.; Maki,Y.J.Org.Chem.1998,63,6947.
  • 4Reiss,C.S.; Komatsu,T.J.Virol.1998,72,4547.
  • 5de Clercq,E.; Tulkens,P.Curr.Opin.Pharmacol.2004,4,429.
  • 6Cresswell,R.M.; Wood,H.C.S.J.Chem.Soc.1960,4768.
  • 7Temple,C.; Kussner,C.L.; Montgomery,A.J.Org.Chem.1968,33,2086.
  • 8Dickey,J.B.; Gray,A.R.Org.Synth.1943,CV 2,60.
  • 9Nubel,G.; Pfleiderer,W.Chem.Ber.1962,95,1605.
  • 10Daves,G.D.; Robins,R.K.; Cheng,C.C.J.Am.Chem.Soc.1962,84,1724.

共引文献23

同被引文献16

  • 1王协璜.醛、酮与格氏试剂的反应[J].安徽师大学报,1994,17(1):75-79. 被引量:3
  • 2冯琼,周智广.肥胖与代谢综合征[J].实用糖尿病杂志,2005,1(2):9-11. 被引量:15
  • 3祁刚,屠树滋.6-硝基香豆素的简便合成[J].生物质化学工程,2006,40(2):23-24. 被引量:5
  • 4黄伟,贾艳秋,孙盛凯.Pd/C催化剂研究进展[J].工业催化,2006,14(10):6-11. 被引量:19
  • 5Wang F, Chen H, Sun X J, et al. Improvement of cognitive defi- cits in SAMP8 mice by 3-n-butylphthalide [J]. Neurol Res, 2014, 36(3) : 224-233.
  • 6Nakai K, Wada R, Iida S, et aL Modeling and Simulation of Orl istat to Predict Weight Loss and Weight Maintenance in Obesity Patients [J]. Drug Metab Pharmaeokinet, 2014, 29(3): 278-282.
  • 7McNeely W, Benfield P. Orlistat [J]. Drugs, 1998, 56(2): 241- 249.
  • 8Zhi J, Melia AT, Eggers H, et al. Review of limited systemic ab sorption of orlistat, a lipase inhibitor, in healthy human volunteers [J]. J Clin Pharmacol, 1995, 35: 1103-1108.
  • 9Fako V E, Zhang J T, Liu J Y. Mechanism of Orlistat Hydrolysis by the Thioesterase of Human Fatty Acid Synthase [J].ACS Catal, 2014, 4.. 3444 3453.
  • 10Khandelwal A, Hall JA, Blagg BS. Synthesis and Structure-Ac- tivity Relationships of EGCG Analogues, a recently IdentifiedHsp90 Inhibitor [J]. J Org Chem, 2013, 78(16), 7859-7884.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部